<< Back to News

System Formulary Update
Adamantanes

Situation
The adamantane class review and formulary standardization was approved by the System Pharmacy and Therapeutics Committee in June 2020.

Background
The following medications were reviewed: amantadine, rimantadine

Assessment/Recommendation
Changes Effective: Tuesday, October 13, 2020

System P&T voted to include the following products on the UNC Health Medication Formulary: 

• Amantadine capsule: 100 mg 
• Amantadine oral syrup: 50 mg/5 mL 

Note: Stock of these products may vary at individual entities

As a result, the following products will be removed from the UNC Health Medication Formulary: 

• Amantadine tablet: 100 mg 
• Rimantadine tablet: 100 mg